Abstract: This article proposes a graphical method to evaluate the feasibility of intentional islanding of distributed synchronous generators. The approach is based on the combination of the ...

Using Science to Improve the BLM Wild Horse and Burro Program: A Way Forward reviews the science that underpins the Bureau of Land Management's oversight of free-ranging horses and burros on federal ...

Donald Trump says another meeting set for next week while warning of ‘very steep’ consequences if Tehran doesn’t make a deal Indirect talks between Iran and the US on the future of Iran’s nuclear ...

Withings' long-term health insights combined with glucose data from Abbott's Lingo empowers a new era of proactive metabolic health. In the initial phase of the partnership between Abbott's Lingo and ...

Lingo, Abbott's first over-the-counter biowearable, expands to Android devices Continuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better ...

Corporate travelers to gain access to 30-day net terms, VAT-compliant invoicing and simplified payments for hotel services in the UK, US and Canada TreviPay, a fully managed B2B payments platform, ...

Invest in distressed properties, rehab them for equity, then rent for passive income using the BRRRR method. Ensure total purchase and rehab costs do not exceed 70% of the after repair value (ARV) to ...

Abstract: When realizing multiagent optimal consensus control, it may encounter the situation that malicious agents transmit false information. Besides, due to the unreliability of information ...

Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...

It is frequently desirable to display the results of computation in a graphical form. This is often done through the use of special hardware such as digital X,Y-plotters. Programmed graphical output ...

As the fervor around ending animal testing in drug development has grown since President Donald Trump started his second term, a group of nonprofits, corporations and regulators has been meeting to ...